Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
uL 35 37 35 37 I-lower_bound

Any 0 3 38 41 O
number 4 10 42 48 O
of 11 13 49 51 O
prior 14 19 52 57 B-treatment
therapies 20 29 58 67 I-treatment
for 30 33 68 71 O
metastatic 34 44 72 82 B-cancer
breast 45 51 83 89 I-cancer
cancer 52 58 90 96 I-cancer
is 59 61 97 99 O
allowed 62 69 100 107 O
; 69 70 107 108 O
patients 71 79 109 117 O
with 80 84 118 122 O
weakly 85 91 123 129 O
estrogen 92 100 130 138 O
receptor 101 109 139 147 O
positive 110 118 148 156 O
breast 119 125 157 163 O
cancer 126 132 164 170 O
who 133 136 171 174 O
received 137 145 175 183 O
any 146 149 184 187 O
number 150 156 188 194 O
of 157 159 195 197 O
endocrine 160 169 198 207 B-treatment
agents 170 176 208 214 I-treatment
for 177 180 215 218 O
metastatic 181 191 219 229 O
breast 192 198 230 236 O
cancer 199 205 237 243 O

Any 0 3 244 247 O
other 4 9 248 253 O
medical 10 17 254 261 B-chronic_disease
or 18 20 262 264 O
psychiatric 21 32 265 276 B-chronic_disease
condition 33 42 277 286 I-chronic_disease
that 43 47 287 291 O
in 48 50 292 294 O
the 51 54 295 298 O
opinion 55 62 299 306 O
of 63 65 307 309 O
the 66 69 310 313 O
investigator 70 82 314 326 O
would 83 88 327 332 O
make 89 93 333 337 O
the 94 97 338 341 O
study 98 103 342 347 O
therapy 104 111 348 355 O
unsafe 112 118 356 362 O
for 119 122 363 366 O
the 123 126 367 370 O
patient 127 134 371 378 O

Aspartate 0 9 379 388 B-clinical_variable
aminotransferase 10 26 389 405 I-clinical_variable
( 27 28 406 407 I-clinical_variable
AST 28 31 407 410 I-clinical_variable
) 31 32 410 411 I-clinical_variable
( 33 34 412 413 B-clinical_variable
serum 34 39 413 418 I-clinical_variable
glutamic 40 48 419 427 I-clinical_variable
oxaloacetic 49 60 428 439 I-clinical_variable
transaminase 61 73 440 452 I-clinical_variable
[ 74 75 453 454 I-clinical_variable
SGOT])/alanine 75 89 454 468 I-clinical_variable
aminotransferase 90 106 469 485 I-clinical_variable
( 107 108 486 487 I-clinical_variable
ALT 108 111 487 490 I-clinical_variable
) 111 112 490 491 I-clinical_variable
( 113 114 492 493 O
serum 114 119 493 498 B-clinical_variable
glutamate 120 129 499 508 I-clinical_variable
pyruvate 130 138 509 517 I-clinical_variable
transaminase 139 151 518 530 I-clinical_variable
[ 152 153 531 532 I-clinical_variable
SGPT 153 157 532 536 I-clinical_variable
] 157 158 536 537 I-clinical_variable
) 158 159 537 538 O
= 160 161 539 540 O
< 161 162 540 541 O
2.5 163 166 542 545 B-upper_bound
x 167 168 546 547 I-upper_bound
institutional 169 182 548 561 I-upper_bound
upper 183 188 562 567 I-upper_bound
limit 189 194 568 573 I-upper_bound
of 195 197 574 576 I-upper_bound
normal 198 204 577 583 I-upper_bound
( 205 206 584 585 O
except 206 212 585 591 O
for 213 216 592 595 O
patients 217 225 596 604 O
with 226 230 605 609 O
liver 231 236 610 615 B-cancer
metastases 237 247 616 626 I-cancer
in 248 250 627 629 O
whom 251 255 630 634 O
AST 256 259 635 638 O
/ 259 260 638 639 O
ALT 260 263 639 642 O
can 264 267 643 646 O
be 268 270 647 649 O
< 271 272 650 651 O
5 273 274 652 653 O
x 275 276 654 655 O
institutional 277 290 656 669 O
upper 291 296 670 675 O
limit 297 302 676 681 O
of 303 305 682 684 O
normal 306 312 685 691 O
) 312 313 691 692 O

Corrected 0 9 693 702 B-clinical_variable
QT 10 12 703 705 I-clinical_variable
interval 13 21 706 714 I-clinical_variable
( 22 23 715 716 I-clinical_variable
QTc 23 26 716 719 I-clinical_variable
) 26 27 719 720 I-clinical_variable
of 28 30 721 723 O
< 31 32 724 725 O
480 33 36 726 729 B-upper_bound
milliseconds 37 49 730 742 I-upper_bound

Creatinine 0 10 743 753 B-clinical_variable
within 11 17 754 760 O
normal 18 24 761 767 O
institutional 25 38 768 781 O
limits 39 45 782 788 O
OR 46 48 789 791 O
creatinine 49 59 792 802 B-clinical_variable
clearance 60 69 803 812 I-clinical_variable
> 70 71 813 814 O
= 71 72 814 815 O
50 73 75 816 818 B-lower_bound
mL 76 78 819 821 I-lower_bound
/ 78 79 821 822 I-lower_bound
min 79 82 822 825 I-lower_bound
for 83 86 826 829 O
patients 87 95 830 838 O
with 96 100 839 843 O
creatinine 101 111 844 854 B-clinical_variable
levels 112 118 855 861 I-clinical_variable
above 119 124 862 867 O
institutional 125 138 868 881 O
normal 139 145 882 888 O

Eastern 0 7 889 896 B-clinical_variable
Cooperative 8 19 897 908 I-clinical_variable
Oncology 20 28 909 917 I-clinical_variable
Group 29 34 918 923 I-clinical_variable
( 35 36 924 925 I-clinical_variable
ECOG 36 40 925 929 I-clinical_variable
) 40 41 929 930 I-clinical_variable
performance 42 53 931 942 I-clinical_variable
status 54 60 943 949 I-clinical_variable
= 61 62 950 951 O
< 62 63 951 952 O
2 64 65 953 954 B-upper_bound
( 66 67 955 956 O
Karnofsky 67 76 956 965 B-clinical_variable
> 77 78 966 967 O
= 78 79 967 968 O
60 80 82 969 971 B-lower_bound
% 82 83 971 972 I-lower_bound
) 83 84 972 973 O

Female 0 6 974 980 B-gender
subjects 7 15 981 989 I-gender
with 16 20 990 994 O
child 21 26 995 1000 O
bearing 27 34 1001 1008 O
potential 35 44 1009 1018 O
must 45 49 1019 1023 O
have 50 54 1024 1028 O
a 55 56 1029 1030 O
negative 57 65 1031 1039 B-pregnancy
pregnancy 66 75 1040 1049 I-pregnancy
test 76 80 1050 1054 O
at 81 83 1055 1057 O
screening 84 93 1058 1067 O
; 93 94 1067 1068 O
child 95 100 1069 1074 O
bearing 101 108 1075 1082 O
potential 109 118 1083 1092 O
is 119 121 1093 1095 O
defined 122 129 1096 1103 O
as 130 132 1104 1106 O
sexually 133 141 1107 1115 O
active 142 148 1116 1122 O
patients 149 157 1123 1131 O
with 158 162 1132 1136 O
menses 163 169 1137 1143 O
less 170 174 1144 1148 O
than 175 179 1149 1153 O
1 180 181 1154 1155 B-lower_bound
year 182 186 1156 1160 I-lower_bound
prior 187 192 1161 1166 I-lower_bound
to 193 195 1167 1169 O
enrollment 196 206 1170 1180 O
, 206 207 1180 1181 O
< 208 209 1182 1183 O
65 210 212 1184 1186 B-upper_bound
years 213 218 1187 1192 I-upper_bound
of 219 221 1193 1195 O
age 222 225 1196 1199 B-age
, 225 226 1199 1200 O
have 227 231 1201 1205 O
no 232 234 1206 1208 O
history 235 242 1209 1216 O
of 243 245 1217 1219 O
oophorectomy 246 258 1220 1232 B-treatment
or 259 261 1233 1235 O
hysterectomy 262 274 1236 1248 B-treatment

History 0 7 1249 1256 O
of 8 10 1257 1259 O
clinically 11 21 1260 1270 O
significant 22 33 1271 1282 O
allergic 34 42 1283 1291 O
reactions 43 52 1292 1301 O
attributed 53 63 1302 1312 O
to 64 66 1313 1315 O
compounds 67 76 1316 1325 O
of 77 79 1326 1328 O
similar 80 87 1329 1336 O
chemical 88 96 1337 1345 O
or 97 99 1346 1348 O
biologic 100 108 1349 1357 O
composition 109 120 1358 1369 O
to 121 123 1370 1372 O
AT13387 124 131 1373 1380 B-allergy_name
or 132 134 1381 1383 O
paclitaxel 135 145 1384 1394 B-allergy_name

History 0 7 1395 1402 O
of 8 10 1403 1405 O
grade 11 16 1406 1411 B-lower_bound
3 17 18 1412 1413 I-lower_bound
- 18 19 1413 1414 O
4 19 20 1414 1415 B-upper_bound
immediate 21 30 1416 1425 O
hypersensitivity 31 47 1426 1442 B-chronic_disease
reaction 48 56 1443 1451 O
to 57 59 1452 1454 O
paclitaxel 60 70 1455 1465 B-allergy_name

Left 0 4 1466 1470 B-clinical_variable
ventricular 5 16 1471 1482 I-clinical_variable
ejection 17 25 1483 1491 I-clinical_variable
fraction 26 34 1492 1500 I-clinical_variable
of 35 37 1501 1503 O
> 38 39 1504 1505 O
50 40 42 1506 1508 B-lower_bound
% 42 43 1508 1509 I-lower_bound
on 44 46 1510 1512 O
baseline 47 55 1513 1521 O
echocardiography 56 72 1522 1538 B-treatment
or 73 75 1539 1541 O
multi 76 81 1542 1547 B-treatment
- 81 82 1547 1548 I-treatment
gated 82 87 1548 1553 I-treatment
acquisition 88 99 1554 1565 I-treatment
( 100 101 1566 1567 I-treatment
MUGA 101 105 1567 1571 I-treatment
) 105 106 1571 1572 I-treatment
scan 107 111 1573 1577 I-treatment

Leukocytes 0 10 1578 1588 B-clinical_variable
> 11 12 1589 1590 O
= 12 13 1590 1591 O
2,000 14 19 1592 1597 B-lower_bound
/ 19 20 1597 1598 I-lower_bound
uL 20 22 1598 1600 I-lower_bound

Life 0 4 1601 1605 B-clinical_variable
expectancy 5 15 1606 1616 I-clinical_variable
of 16 18 1617 1619 O
greater 19 26 1620 1627 O
than 27 31 1628 1632 O
12 32 34 1633 1635 B-lower_bound
weeks 35 40 1636 1641 I-lower_bound

Measurable 0 10 1642 1652 O
disease 11 18 1653 1660 O
is 19 21 1661 1663 O
defined 22 29 1664 1671 O
as 30 32 1672 1674 O
at 33 35 1675 1677 O
least 36 41 1678 1683 O
one 42 45 1684 1687 B-lower_bound
lesion 46 52 1688 1694 O
that 53 57 1695 1699 O
can 58 61 1700 1703 O
be 62 64 1704 1706 O
accurately 65 75 1707 1717 O
measured 76 84 1718 1726 O
in 85 87 1727 1729 O
at 88 90 1730 1732 O
least 91 96 1733 1738 O
one 97 100 1739 1742 O
dimension 101 110 1743 1752 O
( 111 112 1753 1754 O
longest 112 119 1754 1761 O
diameter 120 128 1762 1770 B-clinical_variable
to 129 131 1771 1773 O
be 132 134 1774 1776 O
recorded 135 143 1777 1785 O
for 144 147 1786 1789 O
non 148 151 1790 1793 O
- 151 152 1793 1794 O
nodal 152 157 1794 1799 B-clinical_variable
lesions 158 165 1800 1807 I-clinical_variable
and 166 169 1808 1811 O
short 170 175 1812 1817 O
axis 176 180 1818 1822 O
for 181 184 1823 1826 O
nodal 185 190 1827 1832 O
lesions 191 198 1833 1840 O
) 198 199 1840 1841 O
as 200 202 1842 1844 O
> 203 204 1845 1846 O
= 204 205 1846 1847 O
20 206 208 1848 1850 B-lower_bound
mm 209 211 1851 1853 I-lower_bound
( 212 213 1854 1855 O
> 213 214 1855 1856 O
= 214 215 1856 1857 O
2 216 217 1858 1859 B-lower_bound
cm 218 220 1860 1862 I-lower_bound
) 220 221 1862 1863 O
with 222 226 1864 1868 O
conventional 227 239 1869 1881 O
techniques 240 250 1882 1892 O
or 251 253 1893 1895 O
as 254 256 1896 1898 O
> 257 258 1899 1900 O
= 258 259 1900 1901 O
10 260 262 1902 1904 B-lower_bound
mm 263 265 1905 1907 I-lower_bound
( 266 267 1908 1909 O
> 267 268 1909 1910 O
= 268 269 1910 1911 O
1 270 271 1912 1913 B-lower_bound
cm 272 274 1914 1916 I-lower_bound
) 274 275 1916 1917 O
with 276 280 1918 1922 O
spiral 281 287 1923 1929 B-treatment
computed 288 296 1930 1938 I-treatment
tomography 297 307 1939 1949 I-treatment
( 308 309 1950 1951 I-treatment
CT 309 311 1951 1953 I-treatment
) 311 312 1953 1954 I-treatment
scan 313 317 1955 1959 I-treatment
, 317 318 1959 1960 O
magnetic 319 327 1961 1969 B-treatment
resonance 328 337 1970 1979 I-treatment
imaging 338 345 1980 1987 I-treatment
( 346 347 1988 1989 I-treatment
MRI 347 350 1989 1992 I-treatment
) 350 351 1992 1993 I-treatment
, 351 352 1993 1994 O
or 353 355 1995 1997 O
calipers 356 364 1998 2006 B-treatment
by 365 367 2007 2009 O
clinical 368 376 2010 2018 O
exam 377 381 2019 2023 O

Patients 0 8 2024 2032 O
in 9 11 2033 2035 O
whom 12 16 2036 2040 O
prior 17 22 2041 2046 B-treatment
treatment 23 32 2047 2056 I-treatment
related 33 40 2057 2064 O
toxicities 41 51 2065 2075 O
have 52 56 2076 2080 O
not 57 60 2081 2084 O
recovered 61 70 2085 2094 O
to 71 73 2095 2097 O
grade 74 79 2098 2103 B-upper_bound
1 80 81 2104 2105 I-upper_bound
or 82 84 2106 2108 O
less 85 89 2109 2113 O
( 90 91 2114 2115 O
except 91 97 2115 2121 O
for 98 101 2122 2125 O
alopecia 102 110 2126 2134 B-chronic_disease
) 110 111 2134 2135 O

Patients 0 8 2136 2144 O
must 9 13 2145 2149 O
have 14 18 2150 2154 O
histologically 19 33 2155 2169 O
confirmed 34 43 2170 2179 O
measurable 44 54 2180 2190 O
or 55 57 2191 2193 O
unmeasurable 58 70 2194 2206 O
advanced 71 79 2207 2215 B-chronic_disease
or 80 82 2216 2218 O
metastatic 83 93 2219 2229 B-chronic_disease
breast 94 100 2230 2236 I-chronic_disease
cancer 101 107 2237 2243 I-chronic_disease
for 108 111 2244 2247 O
which 112 117 2248 2253 O
standard 118 126 2254 2262 O
curative 127 135 2263 2271 O
measures 136 144 2272 2280 O
do 145 147 2281 2283 O
not 148 151 2284 2287 O
exist 152 157 2288 2293 O
or 158 160 2294 2296 O
are 161 164 2297 2300 O
no 165 167 2301 2303 O
longer 168 174 2304 2310 O
effective 175 184 2311 2320 O

Patients 0 8 2321 2329 O
who 9 12 2330 2333 O
are 13 16 2334 2337 O
human 17 22 2338 2343 B-chronic_disease
immunodeficiency 23 39 2344 2360 I-chronic_disease
virus 40 45 2361 2366 I-chronic_disease
( 46 47 2367 2368 I-chronic_disease
HIV 47 50 2368 2371 I-chronic_disease
) 50 51 2371 2372 I-chronic_disease
positive 52 60 2373 2381 O
on 61 63 2382 2384 O
highly 64 70 2385 2391 B-treatment
active 71 77 2392 2398 I-treatment
anti 78 82 2399 2403 I-treatment
- 82 83 2403 2404 I-treatment
retroviral 83 93 2404 2414 I-treatment
therapy 94 101 2415 2422 I-treatment
( 102 103 2423 2424 I-treatment
HAART 103 108 2424 2429 I-treatment
) 108 109 2429 2430 I-treatment
will 110 114 2431 2435 O
be 115 117 2436 2438 O
excluded 118 126 2439 2447 O
from 127 131 2448 2452 O
the 132 135 2453 2456 O
study 136 141 2457 2462 O
because 142 149 2463 2470 O
of 150 152 2471 2473 O
the 153 156 2474 2477 O
potential 157 166 2478 2487 O
for 167 170 2488 2491 O
pharmacokinetic 171 186 2492 2507 O
interactions 187 199 2508 2520 O
with 200 204 2521 2525 O
AT13387 205 212 2526 2533 B-treatment
; 212 213 2533 2534 O
in 214 216 2535 2537 O
addition 217 225 2538 2546 O
, 225 226 2546 2547 O
these 227 232 2548 2553 O
patients 233 241 2554 2562 O
are 242 245 2563 2566 O
at 246 248 2567 2569 O
increased 249 258 2570 2579 O
risk 259 263 2580 2584 O
of 264 266 2585 2587 O
lethal 267 273 2588 2594 O
infections 274 284 2595 2605 O
when 285 289 2606 2610 O
treated 290 297 2611 2618 O
with 298 302 2619 2623 O
marrow 303 309 2624 2630 O
- 309 310 2630 2631 I-treatment
suppressive 310 321 2631 2642 I-treatment
therapy 322 329 2643 2650 I-treatment
; 329 330 2650 2651 I-treatment
appropriate 331 342 2652 2663 I-treatment
studies 343 350 2664 2671 I-treatment
will 351 355 2672 2676 I-treatment
be 356 358 2677 2679 I-treatment
undertaken 359 369 2680 2690 I-treatment
in 370 372 2691 2693 I-treatment
patients 373 381 2694 2702 I-treatment
receiving 382 391 2703 2712 I-treatment
combination 392 403 2713 2724 I-treatment
antiretroviral 404 418 2725 2739 I-treatment
therapy 419 426 2740 2747 I-treatment
when 427 431 2748 2752 O
indicated 432 441 2753 2762 O

Patients 0 8 2763 2771 O
who 9 12 2772 2775 O
are 13 16 2776 2779 O
receiving 17 26 2780 2789 O
any 27 30 2790 2793 O
other 31 36 2794 2799 O
investigational 37 52 2800 2815 B-treatment
agents 53 59 2816 2822 I-treatment
within 60 66 2823 2829 O
4 67 68 2830 2831 B-upper_bound
weeks 69 74 2832 2837 I-upper_bound
or 75 77 2838 2840 O
5 78 79 2841 2842 B-upper_bound
half 80 84 2843 2847 I-upper_bound
- 84 85 2847 2848 I-upper_bound
lives 85 90 2848 2853 I-upper_bound
( 91 92 2854 2855 O
whichever 92 101 2855 2864 O
is 102 104 2865 2867 O
shorter 105 112 2868 2875 O
) 112 113 2875 2876 O
prior 114 119 2877 2882 O
to 120 122 2883 2885 O
the 123 126 2886 2889 O
first 127 132 2890 2895 O
dose 133 137 2896 2900 O
of 138 140 2901 2903 O
the 141 144 2904 2907 O
study 145 150 2908 2913 O
regimen 151 158 2914 2921 O

Patients 0 8 2922 2930 O
who 9 12 2931 2934 O
have 13 17 2935 2939 O
had 18 21 2940 2943 O
chemotherapy 22 34 2944 2956 B-treatment
within 35 41 2957 2963 O
4 42 43 2964 2965 B-upper_bound
weeks 44 49 2966 2971 I-upper_bound
( 50 51 2972 2973 O
6 51 52 2973 2974 O
weeks 53 58 2975 2980 O
for 59 62 2981 2984 O
nitrosoureas 63 75 2985 2997 B-treatment
or 76 78 2998 3000 O
mitomycin 79 88 3001 3010 B-treatment
C 89 90 3011 3012 I-treatment
) 90 91 3012 3013 O
prior 92 97 3014 3019 O
to 98 100 3020 3022 O
entering 101 109 3023 3031 O
the 110 113 3032 3035 O
study 114 119 3036 3041 O

Patients 0 8 3042 3050 O
with 9 13 3051 3055 O
known 14 19 3056 3061 O
brain 20 25 3062 3067 B-cancer
metastases 26 36 3068 3078 I-cancer
should 37 43 3079 3085 O
be 44 46 3086 3088 O
excluded 47 55 3089 3097 O
from 56 60 3098 3102 O
this 61 65 3103 3107 O
clinical 66 74 3108 3116 O
trial 75 80 3117 3122 O
because 81 88 3123 3130 O
of 89 91 3131 3133 O
their 92 97 3134 3139 O
poor 98 102 3140 3144 O
prognosis 103 112 3145 3154 O
and 113 116 3155 3158 O
because 117 124 3159 3166 O
they 125 129 3167 3171 O
often 130 135 3172 3177 O
develop 136 143 3178 3185 O
progressive 144 155 3186 3197 B-chronic_disease
neurologic 156 166 3198 3208 I-chronic_disease
dysfunction 167 178 3209 3220 I-chronic_disease
that 179 183 3221 3225 O
would 184 189 3226 3231 O
confound 190 198 3232 3240 O
the 199 202 3241 3244 O
evaluation 203 213 3245 3255 O
of 214 216 3256 3258 O
neurologic 217 227 3259 3269 O
and 228 231 3270 3273 O
other 232 237 3274 3279 O
adverse 238 245 3280 3287 O
events 246 252 3288 3294 O
; 252 253 3294 3295 O
however 254 261 3296 3303 O
, 261 262 3303 3304 O
patients 263 271 3305 3313 O
with 272 276 3314 3318 O
previously 277 287 3319 3329 O
treated 288 295 3330 3337 O
and 296 299 3338 3341 O
stable 300 306 3342 3348 O
brain 307 312 3349 3354 O
metastases 313 323 3355 3365 O
are 324 327 3366 3369 O
eligible 328 336 3370 3378 O
as 337 339 3379 3381 O
long 340 344 3382 3386 O
as 345 347 3387 3389 O
they 348 352 3390 3394 O
are 353 356 3395 3398 O
no 357 359 3399 3401 O
longer 360 366 3402 3408 O
requiring 367 376 3409 3418 O
steroids 377 385 3419 3427 B-treatment
, 385 386 3427 3428 O
completed 387 396 3429 3438 O
radiation 397 406 3439 3448 B-treatment
therapy 407 414 3449 3456 I-treatment
more 415 419 3457 3461 O
than 420 424 3462 3466 O
2 425 426 3467 3468 B-lower_bound
weeks 427 432 3469 3474 I-lower_bound
prior 433 438 3475 3480 I-lower_bound
to 439 441 3481 3483 O
the 442 445 3484 3487 O
first 446 451 3488 3493 O
dose 452 456 3494 3498 O
of 457 459 3499 3501 O
study 460 465 3502 3507 O
regimen 466 473 3508 3515 O
and 474 477 3516 3519 O
have 478 482 3520 3524 O
no 483 485 3525 3527 O
seizures 486 494 3528 3536 B-chronic_disease
or 495 497 3537 3539 O
worsening 498 507 3540 3549 O
neurologic 508 518 3550 3560 O
symptoms 519 527 3561 3569 O

Platelets 0 9 3570 3579 B-clinical_variable
> 10 11 3580 3581 O
= 11 12 3581 3582 O
100,000 13 20 3583 3590 B-lower_bound
/ 20 21 3590 3591 I-lower_bound
uL 21 23 3591 3593 I-lower_bound

Primary 0 7 3594 3601 O
and/or 8 14 3602 3608 O
metastatic 15 25 3609 3619 B-cancer
breast 26 32 3620 3626 I-cancer
tumor 33 38 3627 3632 I-cancer
must 39 43 3633 3637 O
be 44 46 3638 3640 O
negative 47 55 3641 3649 O
for 56 59 3650 3653 O
human 60 65 3654 3659 O
epidermal 66 75 3660 3669 O
growth 76 82 3670 3676 O
factor 83 89 3677 3683 O
receptor 90 98 3684 3692 O
( 99 100 3693 3694 O
HER-2 100 105 3694 3699 O
/ 105 106 3699 3700 O
neu 106 109 3700 3703 O
) 109 110 3703 3704 O
over 111 115 3705 3709 O
- 115 116 3709 3710 O
expression 116 126 3710 3720 O
based 127 132 3721 3726 O
on 133 135 3727 3729 O
immunohistochemistry 136 156 3730 3750 O
( 157 158 3751 3752 O
IHC 158 161 3752 3755 O
) 161 162 3755 3756 O
( 163 164 3757 3758 O
0 164 165 3758 3759 O
or 166 168 3760 3762 O
1 169 170 3763 3764 O
+ 170 171 3764 3765 O
, 171 172 3765 3766 O
2 173 174 3767 3768 O
+ 174 175 3768 3769 O
if 176 178 3770 3772 O
fluorescence 179 191 3773 3785 O
in 192 194 3786 3788 O
- 194 195 3788 3789 O
situ 195 199 3789 3793 O
hybridization 200 213 3794 3807 O
[ 214 215 3808 3809 O
FISH 215 219 3809 3813 O
] 219 220 3813 3814 O
test 221 225 3815 3819 O
is 226 228 3820 3822 O
negative 229 237 3823 3831 O
) 237 238 3831 3832 O
or 239 241 3833 3835 O
FISH 242 246 3836 3840 O
( 247 248 3841 3842 O
HER2 248 252 3842 3846 B-cancer
/ 252 253 3846 3847 O
copy 253 257 3847 3851 O
number 258 264 3852 3858 O
of 265 267 3859 3861 O
centromere 268 278 3862 3872 O
of 279 281 3873 3875 O
chromosome 282 292 3876 3886 O
17 293 295 3887 3889 O
[ 296 297 3890 3891 O
CEP17 297 302 3891 3896 B-clinical_variable
] 302 303 3896 3897 O
ratio 304 309 3898 3903 O
< 310 311 3904 3905 O
2.0 312 315 3906 3909 B-upper_bound
or 316 318 3910 3912 O
< 319 320 3913 3914 O
4 321 322 3915 3916 B-upper_bound
Her-2 323 328 3917 3922 O
/ 328 329 3922 3923 O
neu 329 332 3923 3926 O
signals 333 340 3927 3934 O
per 341 344 3935 3938 O
nucleus 345 352 3939 3946 O
) 352 353 3946 3947 O

Primary 0 7 3948 3955 O
and/or 8 14 3956 3962 O
metastatic 15 25 3963 3973 B-cancer
breast 26 32 3974 3980 I-cancer
tumor 33 38 3981 3986 I-cancer
must 39 43 3987 3991 O
be 44 46 3992 3994 O
negative 47 55 3995 4003 O
for 56 59 4004 4007 O
over 60 64 4008 4012 O
- 64 65 4012 4013 O
expression 65 75 4013 4023 O
of 76 78 4024 4026 O
estrogen 79 87 4027 4035 O
and 88 91 4036 4039 O
progesterone 92 104 4040 4052 O
receptors 105 114 4053 4062 O
; 114 115 4062 4063 O
patients 116 124 4064 4072 O
with 125 129 4073 4077 O
weak 130 134 4078 4082 O
estrogen 135 143 4083 4091 O
receptor 144 152 4092 4100 O
and/or 153 159 4101 4107 O
progesterone 160 172 4108 4120 O
receptor 173 181 4121 4129 O
expression 182 192 4130 4140 O
( 193 194 4141 4142 O
< 194 195 4142 4143 O
10 196 198 4144 4146 B-upper_bound
% 198 199 4146 4147 I-upper_bound
on 200 202 4148 4150 O
immunohistochemistry 203 223 4151 4171 B-clinical_variable
[ 224 225 4172 4173 I-clinical_variable
IHC 225 228 4173 4176 I-clinical_variable
] 228 229 4176 4177 I-clinical_variable
) 229 230 4177 4178 O

Prior 0 5 4179 4184 B-treatment
radiation 6 15 4185 4194 I-treatment
therapy 16 23 4195 4202 I-treatment
within 24 30 4203 4209 O
2 31 32 4210 4211 B-upper_bound
weeks 33 38 4212 4217 I-upper_bound
prior 39 44 4218 4223 I-upper_bound
to 45 47 4224 4226 O
the 48 51 4227 4230 O
first 52 57 4231 4236 O
dose 58 62 4237 4241 O
of 63 65 4242 4244 O
the 66 69 4245 4248 O
study 70 75 4249 4254 B-treatment
regimen 76 83 4255 4262 I-treatment

Prior 0 5 4263 4268 B-treatment
taxane 6 12 4269 4275 I-treatment
is 13 15 4276 4278 O
allowed 16 23 4279 4286 O
( 24 25 4287 4288 O
as 25 27 4288 4290 O
long 28 32 4291 4295 O
as 33 35 4296 4298 O
the 36 39 4299 4302 O
patient 40 47 4303 4310 O
is 48 50 4311 4313 O
not 51 54 4314 4317 O
experiencing 55 67 4318 4330 O
grade 68 73 4331 4336 O
> 74 75 4337 4338 O
1 76 77 4339 4340 B-lower_bound
neuropathy 78 88 4341 4351 B-clinical_variable
and 89 92 4352 4355 O
had 93 96 4356 4359 O
no 97 99 4360 4362 O
history 100 107 4363 4370 O
of 108 110 4371 4373 O
disease 111 118 4374 4381 O
progression 119 130 4382 4393 O
on 131 133 4394 4396 O
a 134 135 4397 4398 O
taxane 136 142 4399 4405 B-treatment
therapy 143 150 4406 4413 I-treatment
within 151 157 4414 4420 O
3 158 159 4421 4422 B-upper_bound
months 160 166 4423 4429 I-upper_bound
prior 167 172 4430 4435 I-upper_bound
to 173 175 4436 4438 O
study 176 181 4439 4444 O
enrollment 182 192 4445 4455 O
) 192 193 4455 4456 O

Prior 0 5 4457 4462 B-treatment
therapy 6 13 4463 4470 I-treatment
with 14 18 4471 4475 I-treatment
AT13387 19 26 4476 4483 I-treatment
or 27 29 4484 4486 I-treatment
another 30 37 4487 4494 I-treatment
HSP90 38 43 4495 4500 I-treatment
inhibitor 44 53 4501 4510 I-treatment

Recent 0 6 4511 4517 O
initiation 7 17 4518 4528 O
of 18 20 4529 4531 O
bone 21 25 4532 4536 B-treatment
modifying 26 35 4537 4546 I-treatment
therapy 36 43 4547 4554 I-treatment
with 44 48 4555 4559 I-treatment
a 49 50 4560 4561 I-treatment
bisphosphonate 51 65 4562 4576 I-treatment
or 66 68 4577 4579 I-treatment
denosumab 69 78 4580 4589 I-treatment
unless 79 85 4590 4596 O
it 86 88 4597 4599 O
has 89 92 4600 4603 O
been 93 97 4604 4608 O
started 98 105 4609 4616 O
more 106 110 4617 4621 O
than 111 115 4622 4626 O
4 116 117 4627 4628 B-lower_bound
weeks 118 123 4629 4634 I-lower_bound
prior 124 129 4635 4640 I-lower_bound
to 130 132 4641 4643 O
the 133 136 4644 4647 O
first 137 142 4648 4653 O
dose 143 147 4654 4658 O
of 148 150 4659 4661 O
the 151 154 4662 4665 O
study 155 160 4666 4671 O
regimen 161 168 4672 4679 O
; 168 169 4679 4680 O
patients 170 178 4681 4689 O
who 179 182 4690 4693 O
are 183 186 4694 4697 O
already 187 194 4698 4705 O
enrolled 195 203 4706 4714 O
in 204 206 4715 4717 O
this 207 211 4718 4722 O
study 212 217 4723 4728 O
can 218 221 4729 4732 O
initiate 222 230 4733 4741 O
bone 231 235 4742 4746 O
modifying 236 245 4747 4756 O
therapy 246 253 4757 4764 O
after 254 259 4765 4770 O
the 260 263 4771 4774 O
first 264 269 4775 4780 O
set 270 273 4781 4784 O
of 274 276 4785 4787 O
re 277 279 4788 4790 O
- 279 280 4790 4791 O
staging 280 287 4791 4798 O
scans 288 293 4799 4804 O
( 294 295 4805 4806 O
> 295 296 4806 4807 O
= 296 297 4807 4808 O
8 298 299 4809 4810 B-lower_bound
weeks 300 305 4811 4816 I-lower_bound
from 306 310 4817 4821 O
cycle 311 316 4822 4827 O
1 317 318 4828 4829 O
, 318 319 4829 4830 O
day 320 323 4831 4834 O
1 324 325 4835 4836 O
) 325 326 4836 4837 O

The 0 3 4838 4841 O
effects 4 11 4842 4849 O
of 12 14 4850 4852 O
AT13387 15 22 4853 4860 B-treatment
on 23 25 4861 4863 O
the 26 29 4864 4867 O
developing 30 40 4868 4878 O
human 41 46 4879 4884 O
fetus 47 52 4885 4890 O
are 53 56 4891 4894 O
unknown 57 64 4895 4902 O
; 64 65 4902 4903 O
for 66 69 4904 4907 O
this 70 74 4908 4912 O
reason 75 81 4913 4919 O
and 82 85 4920 4923 O
because 86 93 4924 4931 O
paclitaxel 94 104 4932 4942 B-treatment
are 105 108 4943 4946 O
known 109 114 4947 4952 O
to 115 117 4953 4955 O
be 118 120 4956 4958 O
teratogenic 121 132 4959 4970 O
; 132 133 4970 4971 O
women 134 139 4972 4977 B-gender
of 140 142 4978 4980 O
child 143 148 4981 4986 O
- 148 149 4986 4987 O
bearing 149 156 4987 4994 O
potential 157 166 4995 5004 O
and 167 170 5005 5008 O
men 171 174 5009 5012 O
must 175 179 5013 5017 O
agree 180 185 5018 5023 B-contraception_consent
to 186 188 5024 5026 I-contraception_consent
use 189 192 5027 5030 I-contraception_consent
adequate 193 201 5031 5039 I-contraception_consent
contraception 202 215 5040 5053 I-contraception_consent
prior 216 221 5054 5059 O
to 222 224 5060 5062 O
study 225 230 5063 5068 O
entry 231 236 5069 5074 O
, 236 237 5074 5075 O
for 238 241 5076 5079 O
the 242 245 5080 5083 O
duration 246 254 5084 5092 O
of 255 257 5093 5095 O
study 258 263 5096 5101 O
participation 264 277 5102 5115 O
and 278 281 5116 5119 O
3 282 283 5120 5121 B-upper_bound
months 284 290 5122 5128 I-upper_bound
after 291 296 5129 5134 I-upper_bound
completion 297 307 5135 5145 O
of 308 310 5146 5148 O
study 311 316 5149 5154 B-treatment
treatment 317 326 5155 5164 I-treatment
administration 327 341 5165 5179 O
; 341 342 5179 5180 O
adequate 343 351 5181 5189 O
contraception 352 365 5190 5203 O
includes 366 374 5204 5212 O
methods 375 382 5213 5220 O
such 383 387 5221 5225 O
as 388 390 5226 5228 O
oral 391 395 5229 5233 B-contraception_consent
contraceptives 396 410 5234 5248 I-contraception_consent
, 410 411 5248 5249 O
double 412 418 5250 5256 B-contraception_consent
barrier 419 426 5257 5264 I-contraception_consent
method 427 433 5265 5271 I-contraception_consent
( 434 435 5272 5273 O
condom 435 441 5273 5279 B-contraception_consent
plus 442 446 5280 5284 I-contraception_consent
spermicide 447 457 5285 5295 I-contraception_consent
or 458 460 5296 5298 O
diaphragm 461 470 5299 5308 B-contraception_consent
) 470 471 5308 5309 O
, 471 472 5309 5310 O
or 473 475 5311 5313 O
abstaining 476 486 5314 5324 B-contraception_consent
from 487 491 5325 5329 I-contraception_consent
sexual 492 498 5330 5336 I-contraception_consent
intercourse 499 510 5337 5348 I-contraception_consent
; 510 511 5348 5349 O
should 512 518 5350 5356 O
a 519 520 5357 5358 O
woman 521 526 5359 5364 B-gender
become 527 533 5365 5371 O
pregnant 534 542 5372 5380 B-pregnancy
or 543 545 5381 5383 O
suspect 546 553 5384 5391 B-pregnancy
she 554 557 5392 5395 I-pregnancy
is 558 560 5396 5398 I-pregnancy
pregnant 561 569 5399 5407 I-pregnancy
while 570 575 5408 5413 O
she 576 579 5414 5417 O
or 580 582 5418 5420 O
her 583 586 5421 5424 O
partner 587 594 5425 5432 O
is 595 597 5433 5435 O
participating 598 611 5436 5449 O
in 612 614 5450 5452 O
this 615 619 5453 5457 O
study 620 625 5458 5463 O
, 625 626 5463 5464 O
she 627 630 5465 5468 O
should 631 637 5469 5475 O
inform 638 644 5476 5482 O
her 645 648 5483 5486 O
treating 649 657 5487 5495 O
physician 658 667 5496 5505 O
immediately 668 679 5506 5517 O

Total 0 5 5518 5523 B-clinical_variable
bilirubin 6 15 5524 5533 I-clinical_variable
less 16 20 5534 5538 O
than 21 25 5539 5543 O
or 26 28 5544 5546 O
equal 29 34 5547 5552 O
to 35 37 5553 5555 O
the 38 41 5556 5559 O
institution 42 53 5560 5571 O
's 53 55 5571 5573 O
upper 56 61 5574 5579 O
limit 62 67 5580 5585 O
of 68 70 5586 5588 O
normal 71 77 5589 5595 O

Uncontrolled 0 12 5596 5608 O
intercurrent 13 25 5609 5621 O
illness 26 33 5622 5629 O
including 34 43 5630 5639 O
, 43 44 5639 5640 O
but 45 48 5641 5644 O
not 49 52 5645 5648 O
limited 53 60 5649 5656 O
to 61 63 5657 5659 O
, 63 64 5659 5660 O
ongoing 65 72 5661 5668 O
or 73 75 5669 5671 O
active 76 82 5672 5678 B-chronic_disease
infection 83 92 5679 5688 I-chronic_disease
, 92 93 5688 5689 O
symptomatic 94 105 5690 5701 O
congestive 106 116 5702 5712 B-chronic_disease
heart 117 122 5713 5718 I-chronic_disease
failure 123 130 5719 5726 I-chronic_disease
, 130 131 5726 5727 O
unstable 132 140 5728 5736 B-chronic_disease
angina 141 147 5737 5743 I-chronic_disease
pectoris 148 156 5744 5752 I-chronic_disease
, 156 157 5752 5753 O
cardiac 158 165 5754 5761 B-chronic_disease
arrhythmia 166 176 5762 5772 I-chronic_disease
, 176 177 5772 5773 O
or 178 180 5774 5776 O
psychiatric 181 192 5777 5788 B-chronic_disease
illness 193 200 5789 5796 I-chronic_disease
/ 200 201 5796 5797 O
social 201 207 5797 5803 O
situations 208 218 5804 5814 O
that 219 223 5815 5819 O
would 224 229 5820 5825 O
limit 230 235 5826 5831 O
compliance 236 246 5832 5842 O
with 247 251 5843 5847 O
study 252 257 5848 5853 O
requirements 258 270 5854 5866 O

